BMPR2 Gene: Bone Morphogenetic Protein Receptor Type 2

Key regulator in pulmonary hypertension and vascular biology

Gene Information Card

Symbol BMPR2
Full Name Bone morphogenetic protein receptor type 2
Gene Type Protein coding
Chromosomal Location 2q33.1-q33.2
NCBI Gene ID 659 ncbi.nlm.nih.gov/gene/659
Ensembl ID ENSG00000204217
UniProt ID Q13873
OMIM ID 600799
HGNC ID 1078
Aliases BMPR-II, BMPR3, PPH1, T-ALK

Description

The BMPR2 gene encodes bone morphogenetic protein receptor type 2, a serine/threonine receptor kinase that binds bone morphogenetic proteins (BMPs) and regulates cellular proliferation, differentiation, and apoptosis. It is critical for vascular homeostasis, particularly in pulmonary endothelial and smooth muscle cells. Mutations in BMPR2 are the most common genetic cause of heritable pulmonary arterial hypertension (PAH).

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Pulmonary arterial hypertension (PAH) Loss-of-function mutations lead to reduced BMPR2 signaling, causing endothelial dysfunction and smooth muscle proliferation in pulmonary arteries. OMIM 600799; ClinVar
Hereditary hemorrhagic telangiectasia (HHT) Rare BMPR2 mutations may contribute to vascular malformations, though less common than in PAH. OMIM 600799; literature
Cancer (various) Altered BMPR2 expression may affect tumor progression in some cancers, but evidence is limited. COSMIC; literature

Expression Profile

Tissue Expression
Tissue nTPM level
Lung High High
Heart Medium Medium
Vascular endothelium High High
Smooth muscle Medium Medium
Brain Low Low
Liver Low Low
Cell Line Expression
Cell Line nTPM Notes
Pulmonary artery endothelial cells (HPAEC) High Key site of BMPR2 action
Pulmonary artery smooth muscle cells (HPASMC) Medium Expressed but lower than endothelium
HEK293 Medium Commonly used for recombinant studies
HeLa Low Low endogenous expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1472C>T (p.Pro491Leu) Missense ~5% of heritable PAH Impairs receptor kinase activity
c.994C>T (p.Arg332Ter) Nonsense ~3% of heritable PAH Truncated protein, loss of function
c.2617C>T (p.Arg873Ter) Nonsense ~2% of heritable PAH Premature stop, loss of function
c.1129delA (p.Thr377ProfsTer) Frameshift Rare Loss of function due to truncation
Mutation functional classification

Loss of Function (LOF)

Most BMPR2 mutations are loss-of-function, leading to haploinsufficiency or dominant-negative effects, reducing BMP signaling.

Gain of Function (GOF)

No clear gain-of-function mutations reported; BMPR2 is primarily a tumor suppressor in vascular context.

Dominant Negative (DN)

Some missense mutations in the kinase domain exert dominant-negative effects by forming inactive heterodimers with wild-type receptors.

Gene Ontology (GO)

• BMP receptor activity • ATP binding
• Protein serine/threonine kinase activity • Transmembrane receptor protein serine/threonine kinase signaling pathway
• Cellular response to BMP stimulus • Positive regulation of apoptosis
• Negative regulation of cell proliferation

Pathways

BMP signaling pathway
TGF-beta signaling pathway
Cytokine-cytokine receptor interaction
Regulation of actin cytoskeleton

Protein Summary

BMPR2 is a type II receptor for bone morphogenetic proteins. It forms heteromeric complexes with type I receptors (e.g., BMPR1A/B) upon ligand binding, leading to phosphorylation of SMAD1/5/8 and subsequent transcriptional regulation. It is essential for vascular integrity; loss of function predisposes to pulmonary arterial hypertension.

Related Products

Product name Cat.No. Species Gene ID
BMPR2 Knockout HEK293 Cell Line EDJ-KQ373 Human 659 Details Get a Quote
BMPR2 Knockout HeLa Cell Line EDJ-KQ18311 Human 659 Details Get a Quote
BMPR2 Knockout A-549 Cell Line EDJ-KQ18572 Human 659 Details Get a Quote
BMPR2 Knockout HCT 116 Cell Line EDJ-KQ18573 Human 659 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: